GlassScriptPhysician profile
Carla S Strater
NPI 1972788008
$801.27
in general payments reported to CMS, 2019-2025
18 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $153 · 2023: $112 · 2024: $37.73 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $237.02 | 2021-2025 | |
| Insulet Corporation | $122.02 | 2021-2025 | Omnipod |
| Novartis Pharmaceuticals Corporation | $90.22 | 2021 | |
| Grifols USA, LLC | $67.24 | 2024-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.25 | 2022-2023 | Jardiance |
| Xeris Pharmaceuticals, INC. | $27.38 | 2021 | |
| Lundbeck LLC | $25.87 | 2025 | Rexulti |
| Abbvie INC. | $24.89 | 2021 | |
| Mylan Specialty L.P. | $21.58 | 2023 | Yupelri |
| Tandem Diabetes Care, INC. | $20.40 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $19.97 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Janssen Pharmaceuticals, INC | $18.52 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.00 | 2023 | Rexulti |
| Philips North America LLC | $16.57 | 2024 | (Ck7) Extended Holter |
| Ibsa Pharma INC. | $15.90 | 2025 | Licart, Flector, Tirosint |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.97 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.85 | 2025 | Zoryve |
| Cequr Corporation | $9.62 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Strater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.